REPLIGEN
Repligen Corporation is a life sciences company focused on the development and commercialization of high-value consumable products used in the process of manufacturing biological drugs. Our bioprocessing products are sold to major life sciences and biopharmaceutical companies worldwide. We are the leading manufacturer of Protein A affinity ligands, a critical component of Protein A resins that are used to separate and purify monoclonal antibody therapeutics. Our ATF (Alternating Tangential Flow)... systems and our growth factor products are used to increase product yield during the fermentation stage of biologic drug manufacturing. In addition, we developed and market an innovative line of “ready-to-use” chromatography columns under our OPUS® and MediaScout® brands that we deliver pre-packed with our customers’ choice of resin. Repligen’s corporate headquarters are in Waltham, MA (USA) and our manufacturing facilities are located in Waltham, MA, Lund, Sweden and Weingarten, Germany.
REPLIGEN
Industry:
Biotechnology Consumer Goods Health Care Manufacturing Pharmaceutical
Founded:
1981-01-01
Address:
Waltham, Massachusetts, United States
Country:
United States
Website Url:
http://www.repligen.com
Total Employee:
1001+
Status:
Active
Contact:
781-250-0111
Email Addresses:
[email protected]
Total Funding:
918.23 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network Font Awesome Domain Not Resolving
Similar Organizations
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Apotex Inc.
APOTEX is a pharmaceutical company committed to R&D, affordable medicines to patients.
AVEO Oncology
AVEO is a biopharmaceutical company that offers drug development strategies for targeted cancer therapeutics.
Edgewell Personal Care
Edgewell Personal Care manufactures and markets a diversified range of personal care products.
Emmaus Medical
Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.
FSD Pharma
FSD Pharma's management’s mission is to transform the facility into the largest hydroponic indoor cannabis facility.
Immutep
Immutep is a biopharmaceutical company developing immunotherapeutics in oncology.
NovaBay Pharmaceuticals
NovaBay Pharmaceuticals is a biopharmaceutical company developing products for the eye care market.
IVERIC bio
IVERIC bio is a biopharmaceutical company developing novel therapies for age-related macular degeneration.
Pharmaron
Pharmaron is a research and development service provider for the pharmaceutical industry.
Recro Pharma
Recro Pharma is a pharmaceutical company developing non-opioid therapeutics for the treatment of pain.
Santen Pharmaceutical
Santen is a Japanese pharmaceutical company specializing in the development and manufacturing of ophthalmic products.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Wisconsin Pharmacal Company
Wisconsin Pharmacal Company is a consumer goods supplier located in Wisconsin.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2021-09-16 | Avitide | Avitide acquired by Repligen | 150 M USD |
| 2021-06-22 | Polymem | Polymem acquired by Repligen | N/A |
| 2020-10-27 | ARTeSYN Biosolutions | ARTeSYN Biosolutions acquired by Repligen | 200 M USD |
| 2019-04-26 | C Technologies | C Technologies acquired by Repligen | 240 M EUR |
| 2017-06-23 | Spectrum Laboratories | Spectrum Laboratories acquired by Repligen | 359 M USD |
| 2016-12-15 | TangenX Technology Corp | TangenX Technology Corp acquired by Repligen | 39 M USD |
| 2016-04-04 | Atoll GmbH | Atoll GmbH acquired by Repligen | 22.5 M USD |
| 2011-10-27 | Novozymes Biopharma Sweden | Novozymes Biopharma Sweden acquired by Repligen | N/A |
Newest Events participated
Participated in BioProduction Congress 2017
on 2017-10-17 as exhibitor
Participated in Viral Safety 2017
on 2017-04-25 as sponsor
Participated in BioProcess International European Summit 2017
on 2017-04-25 as sponsor
Participated in Cell Line Development & Engineering 2017
on 2017-04-24 as sponsor
Participated in BioProcess International West 2017
on 2017-02-27 as sponsor
Participated in BioProcess International West 2017
on 2017-02-27 as exhibitor
Official Site Inspections
http://www.repligen.com Semrush global rank: 1.53 M Semrush visits lastest month: 17.24 K
- Host name: 104.26.11.125
- IP address: 104.26.11.125
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Repligen"
Repligen | Inspiring advances in bioprocessing
Our mission is to inspire advances in bioprocessing as a trusted partner in the production of biologic drugs that improve human health worldwide. The latest addition to the KrosFlo RS …See details»
About Repligen
Our mission is to inspire advances in bioprocessing as a trusted partner in the production of biologic drugs that improve human health worldwide. Repligen is a bioprocessing-focused life sciences company bringing expertise and …See details»
Leadership - Repligen
Repligen Leadership. Meet our Officers, Functional leaders, and Board of Directors.See details»
Repligen - Wikipedia
Repligen Corporation is an American company devoted to the development and production of materials used in the manufacture of biological drugs. The company is based in Waltham, Massachusetts, and was incorporated in Delaware in 1981. A public company, Repligen is listed on the NASDAQ exchange under the symbol RGEN. In February 2014, Repligen had employed 116 people, ab…See details»
Repligen - Crunchbase Company Profile & Funding
Repligen Corporation is a life sciences company focused on the development and commercialization of high-value consumable products used in the process of manufacturing …See details»
Repligen Corporation - LinkedIn
Repligen Corporation | 33,223 followers on LinkedIn. FRAUD ALERT: Please take note that it has come to our attention that individuals purporting to work for Repligen are reaching out to...See details»
Repligen - Org chart - The Org
Explore Repligen's organizational chart. Discover current team members including executives, board members, and advisors.See details»
Org Chart Repligen - The Official Board
Unfortunately, you don't own enough credit to see this new org chart. To continue, you can add a name in one of the org charts you recently viewed or test our Premium membership.See details»
Repligen Corporation Company Profile | Waltham, MA
Find company research, competitor information, contact details & financial data for Repligen Corporation of Waltham, MA. Get the latest business insights from Dun & Bradstreet.See details»
Investors - Repligen
These pages provide visibility to Repligen news, SEC filings, financial and other information that may factor into an investment decision. We welcome your questions or comments.See details»
Repligen Announces CEO Transition Plan | Repligen
WALTHAM, Mass., June 13, 2024 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that its Board of Directors (“Board”) has …See details»
Repligen Company Profile - Office Locations, Competitors, …
Oct 29, 2024 · Repligen is a life sciences company that develops and commercializes bioprocessing technologies and systems. Its business is comprised of four main franchises: …See details»
Decoding Repligen Corp (RGEN): A Strategic SWOT Insight
Feb 24, 2024 · Repligen Corp stands as a key player in the bioprocessing industry, with a diverse product portfolio and global reach. The company's strategic acquisitions and commitment to …See details»
Sustainability - Repligen
At Repligen, sustainability is a strategic priority that impacts all aspects of our organization. Through a balanced approach that blends stakeholder engagement, employee empowerment …See details»
Repligen (RGEN): Company Profile, Stock Price, News, Rankings
Revenue and net income for the four quarters ended on or before April 30, 2023. Market value as of Oct. 13, 2023.See details»
Repligen: The Hidden Gem In Single-Use Solutions For Biopharma ...
Jul 18, 2023 · Repligen, a leading company in biological drug manufacturing, has seen significant growth with sales increasing from $141 million in FY17 to $802 million in FY22, largely due to …See details»
Repligen Corporation - DevelopmentAid
Repligen is a bioprocessing-focused life sciences company bringing over 35 years of expertise and innovation to our customers. We are inspiring advances in bioprocessing through the …See details»
Repligen Corporation (RGEN) Stock Price, Quote & News - Stock …
5 days ago · Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia …See details»
Contact Repligen
Repligen Customer Service is available to provide information and assistance in the following areas: Order placement and/or confirmation; Inquiry about a Repligen product or service; New …See details»
Products - Repligen
Whether you are in fed-batch, hybrid continuous or full continuous mode, or working with therapeutic proteins, gene therapy or vaccines, you can use leading edge solutions from …See details»